Durvalumab(MEDI4736)/Tremelimumab in Combination With Gemcitabine/Cisplatin in Chemotherapy-naïve Biliary Tract Cancer
about
Durvalumab(MEDI4736)/Tremelimumab in Combination With Gemcitabine/Cisplatin in Chemotherapy-naïve Biliary Tract Cancer
description
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
@en
klinisch onderzoek
@nl
name
Durvalumab(MEDI4736)/Tremelimu ...... apy-naïve Biliary Tract Cancer
@en
type
label
Durvalumab(MEDI4736)/Tremelimu ...... apy-naïve Biliary Tract Cancer
@en
prefLabel
Durvalumab(MEDI4736)/Tremelimu ...... apy-naïve Biliary Tract Cancer
@en
P4844
P3098
NCT03046862